4.4 Article

Development and evaluation of a method for concentration and detection of salmonid alphavirus from seawater

期刊

JOURNAL OF VIROLOGICAL METHODS
卷 287, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.jviromet.2020.113990

关键词

Virus concentration; Method development; Droplet digital PCR; Seawater; Membrane filters

资金

  1. Norwegian Research Council [267411]
  2. Norwegian fishery ministry grant: Biosecurity in aquaculture [13055]

向作者/读者索取更多资源

Waterborne viral infections pose a significant threat to fish health, with Salmonid alphavirus (SAV) causing pancreas disease in farmed salmonids. Researchers found that a specific filter combined with a particular eluent can effectively concentrate SAV3, offering potential for further experimental validation.
Waterborne viral infections represent a major threat to fish health. For many viruses, understanding the interplay between pathogens, host and environment presents a major hurdle for transmission. Salmonid alphavirus (SAV) can infect and cause pancreas disease (PD) in farmed salmonids in seawater. During infection, SAV is excreted from infected fish to the seawater. We evaluated two types of filters and four different eluents, for concentration of SAV3. One L of seawater was spiked with SAV3, followed by filtration and virus elution from membrane filters. For the negatively charged MF hydrophilic membrane filter (MF-) combined with NucliSENS (R) lysis buffer the SAV3 recovery was 39.5 +/- 1.8 % by RT-ddPCR and 25.9 +/- 5.7 % by RT-qPCR. The recovery using the positively charged 1 MDS Zeta Plus (R) Virosorb (R) membrane filter (MD+), combined with NucliSENS (R) lysis buffer was 19.0 +/- 0.1 % by RT-ddPCR and 13.3 +/- 3.8 % by RT-qPCR. The limits of quantification (LOQ) and detection (LOD) were estimated to be 5.18 x 10(3) and 2.0 x 10(2) SAV3 copies/L of natural seawater, by RT-ddPCR. SAV3 recovery from small volumes of seawater, and the requirement for standard laboratory equipment, suggest the MF-filter combined with NucliSENS (R) lysis buffer would be a candidate for further validation in experimental trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据